JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]
DaVita Healthcare (NYSE:DVA) owes $383.5 million in damages, $375 million of which is in punitive damages, to relatives of dialysis patients who died after treatment at DaVita’s dialysis centers, according to court documents. Plaintiffs in the case claimed that their relatives on dialysis care died due negligence and DaVita using GranuFlo and NaturaLyte solutions, made by Fresenius […]
Former employees at the Centers for Medicare & Medicaid Services used confidential information on Medicare reimbursement changes for radiation treatments and dialysis in a nearly $4 million insider trading scheme, federal prosecutors and the U.S. Securities & Exchange Commission alleged today. An SEC lawsuit and a criminal complaint accuse political consultant David Blaszczak, founder of Precipio Health Strategies […]
A Texas federal judge today extended a block on a federal rule that would require dialysis providers to disclose any charitable assistance patients receive to insurers. The indefinite extension was granted by U.S. District Judge Amos Mazzant in Sherman, Texas, in a suit filed by dialysis providers including Fresenius Medical Care (NYSE:FMS), DaVita. The rule, which was announced by […]
B. Braun Medical said it’s entered an agreement with DaVita to provide its Dialog+ dialysis equipment to fill a portion of DaVita’s product requirement.
Bethlehem, Pa.-based Braun has been a leader in the dialysis field for years and has a long-standing relationship with DaVita. The Dialog+ system allows patients to have the greatest number of possible configurations for individual treatment.
CVRx said it added $12 million from DaVita HealthCare, Ysios Capital and others to its Series F funding round, taking the total for the round to $42 million.
The Minneapolis-based company is planning to use the money to advance clinical trials and expand its international commercial footprint, according to a press release. CVRx developed the Barostim Neo, a pacemaker-like device designed to treat hypertension.
Updated July 2, 2013, at 3:45 p.m. with comment from NxStage Medical.
Updated July 2, 2013, at 5 p.m. with comment from Fresenius.
Dialysis technology makers slid hard today after the Center for Medicare & Medicaid Services proposed a reimbursement decrease of more than 9% for 2014.
Laser-based lab equipment maker Hamilton Thorne Inc. (TSX-V: HTL) has named company president David Wolf as CEO. Wolf takes over the post from company co-founder Meg Spencer, who will remain with Hamilton Thorne as chairman of the board and a chief strategic advisor.
Wolf, who helped take the company public, has been president of the Hamilton Thorne since 2009 and will continue to hold that role along with the additional CEO responsibilities.
Updated: 8/11/2011 1:15 p.m.
Kidney care services provider DaVita Inc. (NYSE:DVA) is taking on the environmental footprint left by its customers by launching a pilot program to recycle some of the waste from dialysis centers.